Pharmaceuticals
-
New support for COVID vaccine in pregnancy
A new study has found no evidence of adverse pregnancy outcomes with COVID-19 mRNA vaccines. Read more
-
COVID-19 vaccine technique tested for heart disease
The techniques perfected in COVID-19 vaccines could be used to help repair damaged heart muscle following a heart attack, European researchers have reported. Read more
-
Low deaths in communities with high COVID-19 vaccine rates
People living in communities with high COVID-19 vaccination rates record fewer deaths from the virus, a new US study has found. Read more
-
Using swarm learning to diagnose cancer
British researchers have reported a new method of diagnosing cancer using artificial intelligence in the laboratory. Read more
-
Promising start for on-demand contraceptive pill study
A “promising candidate” for an on-demand contraceptive pill has been identified in preliminary research, it was announced today. Read more
-
Million milestone passed for malaria vaccine
More than one million children in three African countries have received at least one dose of the world’s first malaria vaccine as part of a pilot programme. Read more
-
Telomere length associated with COVID-19 mortality
Telomeres may influence the severity of COVID-19 and the risk of dying from the disease, particularly in women, a European conference is to hear. Read more
-
Make-up of SARS-CoV-2 outer envelope revealed
The molecular make-up of the fatty outer envelope of SARS-CoV-2 has been detailed for the first time, offering a new target for antivirals, British scientists have announced. Read more
-
Single HPV jab ‘sufficient’
A single dose of the human papillomavirus vaccine gives as good protection as two doses, experts have ruled. Read more
-
Low heart risk from COVID jab
There is no significant rise in cases of myopericarditis after COVID-19 vaccination programmes, according to a new analysis. Read more
